questionText: To ask the Secretary of State for Health and Social Care, what guidance his Department provides to health boards on whether they should consider (a) the mental health impacts of alopecia and (b) other factors prior to prescribing Ritlecitinib.
answerText: The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...
heading: Ritlecitinib: Alopecia